Mark Rosenbloom
LIFEFORCE Medical Institute, USA
Title: Novel Approach to Pharmacogenomics: An Electronic Methodology Utilizing Predictive and Known Pharmacogenomics Drug/Gene Interactions for Clinical Prescribing and Patient Monitoring
Biography
Biography: Mark Rosenbloom
Abstract
With over 50 important pharmacogenomic genes, each with multiple variants, and over 2,000 drugs, the potential drug/gene interactions total in the hundreds of thousands.
It is impractical and virtually impossible to study all potential drug/gene interactions, let alone incorporating drug/drug/gene and drug/gene/gene interactions.
This extensive number of possible drug/gene interactions creates a challenge to implementing pharmacogenomics in practice. Now, through a methodology developed by Dr. Mark Rosenbloom, MD and based on pharmacokinetic and pharmacodynamic principles, clinicians can overcome this challenge by accessing known and predicted drug/gene interactions within seconds from a mobile phone, tablet, or computer.
Dr. Rosenbloom will demonstrate his recently developed drug/gene interactions tool, and a discussion of the methodology used to deliver known and predicted drug/gene, drug/drug/gene, and drug/gene/gene interactions. Designed to provide immediately actionable information to clinicians, the electronic methodology allows for better informed clinical prescribing and patient monitoring decisions.
The methodology is readily adaptable for hospital-wide systems and electronic medical records. The end-result is a clinician, presented with known drug/gene interactions and an array of potential predicted interactions, providing better informed clinical prescribing and patient monitoring decisions. The methodology will be discussed and examples will be given.